Get the app!
Back to Companies

Janux Therapeutics, Inc.

JANXNasdaqCIK: 0001817713

Janux Therapeutics, Inc. (JANX) shows 16 recent insider filings from 9 insiders, with all of them on the sell side. With $0 in purchases and $958.1K in sales, the recent tape is heavily weighted toward selling (net sales of $958.1K). Campbell David Alan is the most active by dollar volume, and the single largest transaction was $4.7M by Campbell David Alan. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume
$14.8M
Purchases
$0
Sales
$958.1K
Unique Insiders
9

Recent Insider Trades

16 loaded
Jul 31JANX
Janux Therapeutics, Inc.
Campbell David AlanInsiderGift$0
Jul 10JANX
Janux Therapeutics, Inc.
Campbell David AlanInsiderExercise$58.9K
Jun 12JANX
Janux Therapeutics, Inc.
RA CAPITAL MANAGEMENT, L.P.InsiderGrant$211.7K
Jun 4JANX
Janux Therapeutics, Inc.
Doyle Janeen NoelInsiderSell$56.9K
May 13JANX
Janux Therapeutics, Inc.
Dobek MariaInsiderSell$28.9K
Feb 4JANX
Janux Therapeutics, Inc.
Go WilliamInsiderGrant$2.2M
Feb 4JANX
Janux Therapeutics, Inc.
Go WilliamInsiderOther$0
Jan 2JANX
Janux Therapeutics, Inc.
McIver ZachariahInsiderSell$37.3K
Jan 2JANX
Janux Therapeutics, Inc.
Dobek MariaInsiderSell$20.1K
Jan 2JANX
Janux Therapeutics, Inc.
Winter Charles M.InsiderSell$33.0K
Jan 2JANX
Janux Therapeutics, Inc.
Campbell David AlanInsiderSell$110.8K
Jan 2JANX
Janux Therapeutics, Inc.
Meyer Andrew HollmanInsiderSell$25.8K
Jan 2JANX
Janux Therapeutics, Inc.
DiRaimondo ThomasInsiderSell$34.4K
Jan 2JANX
Janux Therapeutics, Inc.
Doyle Janeen NoelInsiderGrant$1.7M
Dec 3JANX
Janux Therapeutics, Inc.
Meyer Andrew HollmanInsiderSell$109.9K
Oct 30JANX
Janux Therapeutics, Inc.
Meyer Andrew HollmanInsiderSell$501.0K

16 filings